BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 10887369)

  • 1. Three year seroepidemiological study of varicella-zoster virus in São Paulo, Brazil.
    Yu AL; Costa JM; Amaku M; Pannuti CS; Souza VA; Zanetta DM; Burattini MN; Massad E; Azevedo RS
    Rev Inst Med Trop Sao Paulo; 2000; 42(3):125-8. PubMed ID: 10887369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Varicella transmission in two samples of children with different social behaviour in the State of São Paulo, Brazil.
    Yu AL; Amaku M; Burattini MN; Massad E; Azevedo RS
    Epidemiol Infect; 2001 Dec; 127(3):493-500. PubMed ID: 11811883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Varicella-zoster virus seroprevalence in children and adolescents in the pre-varicella vaccine era, Germany.
    Wiese-Posselt M; Siedler A; Mankertz A; Sauerbrei A; Hengel H; Wichmann O; Poethko-Müller C
    BMC Infect Dis; 2017 May; 17(1):356. PubMed ID: 28525973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A seroepidemiologic survey of the prevalence of varicella-zoster virus in the pediatric population in two university hospitals in Brazil.
    Semenovitch I; Lupi O
    Int J Dermatol; 2003 Mar; 42(3):193-6. PubMed ID: 12653913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroprevalence of varicella-zoster virus in Polish population.
    Siennicka J; Trzcińska A; Rosińska M; Litwińska B
    Przegl Epidemiol; 2009; 63(4):495-9. PubMed ID: 20120946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How reliable is the history of chickenpox? Varicella serology among children up to 14 years of age.
    Kavaliotis J; Petridou S; Karabaxoglou D
    Int J Infect Dis; 2003 Dec; 7(4):274-7. PubMed ID: 14656418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroepidemiology of varicella-zoster virus infection in a cosmopolitan city (Erzurum) in the eastern Turkey.
    Alp H; Altinkaynak S; Ertekin V; Kiliçaslan B; Giiraksin A
    Health Policy; 2005 Apr; 72(1):119-24. PubMed ID: 15760704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seroprevalence of varicella-zoster virus in the German population.
    Wutzler P; Färber I; Wagenpfeil S; Bisanz H; Tischer A
    Vaccine; 2001 Oct; 20(1-2):121-4. PubMed ID: 11567755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The seroepidemiology of varicella in Italy.
    Gabutti G; Penna C; Rossi M; Salmaso S; Rota MC; Bella A; Crovari P;
    Epidemiol Infect; 2001 Jun; 126(3):433-40. PubMed ID: 11467800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Varicella seroprevalence in Turkish population in Cyprus.
    Kurugol Z; Koturoglu G; Aksit S; Ozacar T
    Acta Paediatr; 2007 Jun; 96(6):861-3. PubMed ID: 17465984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of IgG varicella zoster virus antibodies in the Kuikuro and Kaiabi indigenous communities in Xingu National Park, Brazil, before varicella vaccination.
    Lafer MM; de Moraes-Pinto MI; Weckx LY
    Rev Inst Med Trop Sao Paulo; 2005; 47(3):139-42. PubMed ID: 16021286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The seroepidemiology of the varicella-zoster virus in children and adolescents].
    Gil Miguel A; Lasheras Lozano ML; Jiménez García R; Calle Purón ME; Santos Santos M; Rey Calero J; Martín Hernández D
    Aten Primaria; 1993 May; 11(8):416-8. PubMed ID: 8388262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seroprevalence of hepatitis A virus and varicella zoster antibodies in a Javanese community (Yogyakarta, Indonesia).
    Juffrie M; Graham RR; Tan RI; Widjaja S; Mulyadi S; Weil J; Bock HL
    Southeast Asian J Trop Med Public Health; 2000 Mar; 31(1):21-4. PubMed ID: 11023059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in age related seroprevalence of antibody to varicella zoster virus: impact on vaccine strategy.
    Kudesia G; Partridge S; Farrington CP; Soltanpoor N
    J Clin Pathol; 2002 Feb; 55(2):154-5. PubMed ID: 11865016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Varicella-zoster virus seroprevalence in children between 0-15 years old].
    Savaş S; Dallar Y; Arikan I; Onde U
    Mikrobiyol Bul; 2004; 38(1-2):69-75. PubMed ID: 15293904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroprevalence of Varicella-Zoster virus IgG antibodies in Swiss children during the first 16 months of age.
    Heininger U; Desgrandchamps D; Schaad UB
    Vaccine; 2006 Apr; 24(16):3258-60. PubMed ID: 16459000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroprevalence of varicella-zoster virus among pregnant women in Fayoum Governorate, Egypt.
    Ibrahim EG; Abdel Wahed WY; Eid HM; Deeb WS
    J Egypt Public Health Assoc; 2019; 94(1):2. PubMed ID: 30686830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Varicella zoster virus in American Samoa: seroprevalence and predictive value of varicella disease history in elementary and college students.
    Mahamud A; Leung J; Masunu-Faleafaga Y; Teshale E; Williams R; Dulski T; Thieme M; Garcia P; Schmid DS; Bialek SR
    Epidemiol Infect; 2014 May; 142(5):1002-7. PubMed ID: 23890292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The utility of serologic testing for varicella in an adolescent population.
    Ronan K; Wallace MR
    Vaccine; 2001 Sep; 19(32):4700-2. PubMed ID: 11535319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Varicella zoster virus infection occurs at a relatively young age in The Netherlands.
    van Lier A; Smits G; Mollema L; Waaijenborg S; Berbers G; van der Klis F; Boot H; Wallinga J; de Melker H
    Vaccine; 2013 Oct; 31(44):5127-33. PubMed ID: 23973248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.